Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Autoimmunity. 2013 Jan 9;46(3):188–204. doi: 10.3109/08916934.2012.746671

Table 1.

B cell profiles of LamH Tg+ and Non-Tg spleen (A) and Bone marrow (B) by lupus strain a

BWF1 BXSB NZB MRL/lpr
Non-Tg Tg+ Non-Tg Tg+ Non-Tg Tg+ Non-Tg Tg+
A. Spleen
B cells
(millions)
23.2 ± 6.1
(13)
5.4 ± 2.9*
(15)
60.6 ± 26.7
(31)
10.6 ± 5.3*
(41)
18.2 ± 4.0
(18)
3.6 ± 1.6*
(24)
31.2± 18.9
(11)
6.4 ± 4.7*
(15)
% B cell decrease
(vs Non-Tg)
- 76.7 - 82.5 - 80.2 - 75.6
%IgMa+ 3.3 ± 3.1
(13)
82.6 ± 8.9*
(15)
1.7 ± 1.8
(30)
86.7 ± 6.5*
(41)
1.9 ± 1.3
(18)
61.1 ± 11.5*
(24)
%IgMb+ 84.3 ± 7.9
(13)
15.8 ± 6.9*
(15)
82.6 ± 8.3
(30)
12.9 ± 4.9*
(41)
80.9 ± 7.2
(18)
24.4 ± 12.7*
(24)
%Lambda+ 3.2 ± 1.1
(13)
2.0 ± 1.0*
(15)
3.7 ± 1.5
(19)
7.1 ± 2.5*
(26)
5.5 ± 1.8
(11)
8.9 ± 4.3*
(14)
11.6± 9.1
(7)
6.9 ± 3.8
(7)
Surface Ig
MFI
1.0 ± 0.2
(13)
0.6 ± 0.3*
(15)
1.0 ± 0.1
(19)
1.0 ± 0.1
(21)
1.0 ± 0.1
(13)
0.6 ± 0.1*
(16)
1.0 ± 0.1
(7)
0.4 ± 0.2*
(7)
B. Bone Marrow
% B cells
Of lymph
42.9 ± 11.7
(13)
35.1 ± 15.4
(15)
45.6 ± 13.1
(23)
27.5 ± 10.7*
(27)
32.8 ± 13.3
(18)
23.4 ± 10.3*
(24)
10.8 ± 5.4
(5)
3.7 ± 1.9
(5)
%IgM+ of
B cells
44.0 ± 7.5
(13)
30.3 ± 6.1*
(15)
51.5 ± 16.9
(26)
34.6 ± 7.5*
(34)
47.6 ± 16.1
(17)
33.3 ± 20.2*
(20)
37.8 ± 14.7
(5)
27.8 ± 7.2
(5)
a

Data expressed as mean ± SD; number of subjects is shown in parenthesis. Average age of subjects included in this table, in months: BWF1 non-Tg: 3.4 ± 1.5, Tg+: 3.7 ± 1.3; BXSB non-Tg: 4.6 ± 2.3, Tg+: 5.1 ± 2.2; NZB non-Tg: 3.9 ± 2.0, Tg+ 4.5 ± 2.3; MRL/lpr non-Tg: 4.6 ± 1.8, Tg+ 4.4 ± 1.5.

*

p<0.05 versus non-Tg of the same strain.